Impaired Proteolysis of Noncanonical RAS Proteins Drives Clonal Hematopoietic Transformation.
Sisi ChenRahul S VedulaAntonio Cuevas-NavarroBin LuSimon J HoggEric WangSalima BenbarcheKatherine KnorrWon Jun KimRobert F StanleyHana ChoCaroline EricksonMichael SingerDan CuiSteven TittleyBenjamin H DurhamTatiana S PavletichElise FialaMichael F WalshDaichi InoueSebastien MonetteJustin TaylorNeal X RosenFrank McCormickR Coleman LindsleyHatice Ulku OsmanbeyogluOmar Abdel-WahabPublished in: Cancer discovery (2022)
Here we identify that impairing proteolysis of the noncanonical RAS GTPases RIT1 and MRAS via LZTR1 downregulation or leukemia-associated mutations stabilizing RIT1 enhances MAP kinase activation and drives leukemogenesis. Reducing the abundance of GTP-bound KRAS and NRAS overcomes the resistance to FLT3 kinase inhibitors associated with LZTR1 downregulation in leukemia. This article is highlighted in the In This Issue feature, p. 2221.